Figure 1From: Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitusIncidence of Gastrointestinal side effects before and after switchover to extended release metformin XR in patients completing the 6 month study. * vs metformin p = 0.013.Back to article page
